GSP® INSTRUMENT
The automated high throughput platform for screening disorders in newborns using both DELFIA® immunoassay and enzymatic technologies. The GSP® newborn screening system offers outstanding accuracy and reliability, coupled with high efficiency and user-friendliness. It brings the future of neonatal screening to your laboratory, helping you provide children with a healthier start to life.
Using dried blood spot samples (DBS) the GSP platform reduced hands-on stages and reduced risk of error through automation from plate loading to results output.